Profound Medical (PROF) Earnings Date, Estimates & Call Transcripts $5.47 +0.24 (+4.59%) Closing price 04:00 PM EasternExtended Trading$5.45 -0.02 (-0.37%) As of 05:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Profound Medical Earnings Summary Upcoming Earnings DateMay. 8After Market ClosesEstimatedConsensus EPS (Mar. 6) -$0.31 Actual EPS (Mar. 6) -$0.20 Beat By $0.11 Actual Revenue (Mar. 6) $4.18MProfound Medical issued Q4 2024 earnings on March 6, 2025, reporting an EPS of -$0.20, which beat analysts' consensus estimates of -$0.31 by $0.11. Quarterly revenue was reported to be $4.18 million, below the consensus estimate of $5.92 million. With a trailing EPS of -$1.12, Profound Medical's earnings are expected to grow next year, from ($1.12) to ($0.78) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Annual Report (10-K)PROF Upcoming EarningsProfound Medical's Q1 2025 earnings is scheduled for Thursday, May 8, 2025, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportPowered by Get Profound Medical Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Profound Medical and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataPROF Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PROF Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Profound Medical Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20251-$0.26-$0.26-$0.26Q2 20251-$0.26-$0.26-$0.26Q3 20251-$0.26-$0.26-$0.26Q4 20251-$0.26-$0.26-$0.26 FY 2025 4 -$1.04 -$1.04 -$1.04 Q1 20261-$0.24-$0.24-$0.24Q2 20261-$0.20-$0.20-$0.20Q3 20261-$0.19-$0.19-$0.19Q4 20261-$0.14-$0.14-$0.14 Profound Medical Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)-------3/6/2025Q4 2024-$0.31-$0.20+$0.11-$0.20$5.92M$4.18M11/7/2024Q3 2024-$0.33-$0.38 -$0.05-$0.38$3.30M$2.83M8/8/2024Q2 2024-$0.28-$0.28--$0.28$2.50M$2.23M5/9/2024Q1 2024-$0.31-$0.26+$0.05-$0.26$2.40M$1.91M3/7/2024Q4 2023-$0.28-$0.42 -$0.14-$0.42$1.90M$2.01M11/2/2023Q3 2023-$0.32-$0.26+$0.06-$0.26$2.40M$1.73M8/9/2023Q2 2023-$0.31-$0.35 -$0.04-$0.35$2.05M$1.60M5/10/2023Q1 2023-$0.38-$0.32+$0.06-$0.32$1.85M$1.86M Profound Medical Earnings - Frequently Asked Questions When is Profound Medical's earnings date? Profound Medical has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on PROF's earnings history. Did Profound Medical beat their earnings estimates last quarter? In the previous quarter, Profound Medical (NASDAQ:PROF) reported ($0.20) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.31) by $0.11. Learn more on analysts' earnings estimate vs. PROF's actual earnings. How can I listen to Profound Medical's earnings conference call? The conference call for Profound Medical's latest earnings report can be listened to online. Listen to Conference Call How can I read Profound Medical's conference call transcript? The conference call transcript for Profound Medical's latest earnings report can be read online. Read Transcript How much revenue does Profound Medical generate each year? Profound Medical (NASDAQ:PROF) has a recorded annual revenue of $10.68 million. How much profit does Profound Medical generate each year? Profound Medical (NASDAQ:PROF) has a recorded net income of -$28.57 million. PROF has generated -$1.12 earnings per share over the last four quarters. What is Profound Medical's EPS forecast for next year? Profound Medical's earnings are expected to grow from ($1.12) per share to ($0.78) per share in the next year. More Earnings Resources from MarketBeat Related Companies OrthoPediatrics Earnings Results Beta Bionics Earnings Results Treace Medical Concepts Earnings Results ClearPoint Neuro Earnings Results Delcath Systems Earnings Results NeuroPace Earnings Results Semler Scientific Earnings Results Tactile Systems Technology Earnings Results Nano-X Imaging Earnings Results Neuronetics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Is Reddit Stock a Buy, Sell, or Hold After Earnings Release?Warning or Opportunity After Super Micro Computer's EarningsAmazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2Palantir Earnings: 1 Bullish Signal and 1 Area of ConcernVisa Q2 Earnings Top Forecasts, Adds $30B Buyback Plan This page (NASDAQ:PROF) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profound Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Profound Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PROF Stock Free PROF Stock Alerts